bladder cancer
Conditions
Interventions
Experimental group:Innovative ileal neobladder
Control group:Traditional ileal neobladder
Sponsors
The Second Affiliated Hospital of Kunming Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1. Locally resectable muscle-invasive bladder cancer without distant metastasis (T2-4a, M0). 2. High-risk non-muscle-invasive bladder cancer, T1G3 tumor, carcinoma in situ (Tis) ineffective BCG therapy. 3. Recurrent non-muscle-invasive bladder cancer. 4. Preoperative or intraoperative urethral incision margin negative. 5. No active inflammatory bowel disease or previous extensive bowel resection.
Exclusion criteria
Exclusion criteria: 1. There is distant metastasis, or the physical condition cannot tolerate surgery. 2. Positive urethral resection margin before or during surgery. 3. Presence of anterior urethral stricture or preoperative urinary control dysfunction. 4. Patients with incomplete collection of clinical data.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Daytime continent; | — |
Secondary
| Measure | Time frame |
|---|---|
| Difficulty urinating;urodynamic examination;Postoperative bowel function recovery time; | — |
Countries
China
Contacts
Public ContactJiongming Li
The Second Affiliated Hospital of Kunming Medical University
Outcome results
None listed